sivelestat has been researched along with Multiple Organ Failure in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Imai, Y; Kawahara, M; Kuba, K; Mizushima, T; Sugizaki, T; Tamura, F; Tanaka, KI | 1 |
| Andoh, K; Hoshi, K; Kaise, A; Kato, M; Kurosawa, S; Satoh, D | 1 |
| Imamura, M; Mikami, Y; Takahashi, H; Yamauchi, H | 1 |
3 other study(ies) available for sivelestat and Multiple Organ Failure
| Article | Year |
|---|---|
Evaluation of Lecithinized Superoxide Dismutase for the Prevention of Acute Respiratory Distress Syndrome in Animal Models.
Topics: Animals; Cecum; Dexamethasone; Disease Models, Animal; Glycine; Ligation; Lipopolysaccharides; Lung Injury; Male; Mice; Mice, Inbred ICR; Multiple Organ Failure; Phosphatidylcholines; Punctures; Reactive Oxygen Species; Respiration, Artificial; Respiratory Distress Syndrome; Sulfonamides; Superoxide Dismutase | 2017 |
Sivelestat, a neutrophil elastase inhibitor, reduces mortality rate of critically ill patients.
Topics: Aged; Aged, 80 and over; Critical Illness; Female; Glycine; Hospitals, University; Hospitals, Urban; Humans; Intensive Care Units; Japan; Length of Stay; Leukocyte Elastase; Male; Middle Aged; Multiple Organ Failure; Respiratory Distress Syndrome; Retrospective Studies; Sulfonamides; Treatment Outcome | 2005 |
Effect of a specific synthetic inhibitor of neutrophil elastase (ONO-5046) on the course of acute hemorrhagic pancreatitis in dogs.
Topics: alpha-Macroglobulins; Amylases; Animals; Blood Pressure; Calcium; Disease Models, Animal; Dogs; Glycine; Hematocrit; Hemorrhage; Leukocyte Count; Lipopolysaccharides; Multiple Organ Failure; Organ Size; Pancreatitis; Serine Proteinase Inhibitors; Sulfonamides | 1998 |